Agilent Technologies Lowers Fiscal Outlook as Profit 1Q Falls

Dow Jones
27 Feb

By Connor Hart

Agilent Technologies lowered its fiscal 2025 outlook, as profit narrowed in its fiscal first quarter.

The laboratory-supply and services company on Wednesday said it now expects revenue of $6.68 billion to $6.76 billion, down from a prior outlook for $6.79 billion to $6.87 billion. Analysts surveyed by FactSet expect sales of $6.83 billion.

The Santa Clara, Calif., company backed its adjusted per-share earnings outlook of $5.54 to $5.61 for the year, the midpoint of which is just below the $5.56 that analysts modeled.

For its fiscal second quarter, Agilent guided for adjusted per-share earnings of $1.25 to $1.28 on revenue of $1.61 billion to $1.65 billion. Analysts polled by FactSet forecast adjusted earnings of $1.31 a share on revenue of $1.65 billion.

Shares fall 4.1%, to $129.01, in after-hours trading.

In the quarter ended Jan. 31, Agilent reported net income of $318 million, or $1.11 a share, compared with $348 million, or $1.18 a share, a year earlier.

Adjusted per-share earnings came in at $1.31, topping the $1.27 that analysts surveyed by FactSet expected.

Revenue increased 1.4% to $1.68 billion, roughly in line with estimates.

Write to Connor Hart at connor.hart@wsj.com

 

(END) Dow Jones Newswires

February 26, 2025 16:58 ET (21:58 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10